Acadian Asset Management LLC Myovant Sciences Ltd. Transaction History

Acadian Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$11.38 - $16.4 $117,669 - $169,575	-10,340 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$14.31 - $23.87 $6,782 - $11,314	-474 Reduced 4.38%	10,340 $160,000
Q3 2021 Nov 12, 2021	BUY	$18.94 - $26.99 $80,551 - $114,788	4,253 Added 64.82%	10,814 $242,000
Q2 2021 Aug 11, 2021	SELL	$17.07 - $24.56 $3.08 Million - $4.44 Million	-180,702 Reduced 96.5%	6,561 $150,000
Q1 2021 May 11, 2021	BUY	$20.46 - $25.18 $3.83 Million - $4.72 Million	187,263 New	187,263 $3.85 Million

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.